SlideShare a Scribd company logo
*Corresponding Author: Hamid Galedari 118
1st
International Conference on Medicine, Public Health and Biological Sciences (MPHBS)
Study of MMP-9 gene expression in the presence of Sialic acid in human Glial
cell line
Narjes Khatoun Shabani Sadr1
, Mouhammad Shafiei1
, Hamid Galedari1,*
, Alireza Khirolah2
1
Department of Genetic, Faculty of Sciences, Shahid Chamran University of Ahvaz, Ahvaz, Iran.
2
Department of Biochemistry, Medical School, Cellular and Molecular Research Center, Ahvaz Jundishapur
University of Medical Science, Ahvaz, Iran.
Abstract
Introduction: Sialic acid (N-acetylneuraminic acid, NANA) is found at all cell surfaces of vertebrates which can
cause many different reactions, such as starting or inhibiting the immune response, the activating of the
complement system and cell signaling. Sialic acid involvement in the signaling pathways leading to MMP-9
expression in Glial cells is unclear. Therefore, this study investigated the relationship between MMP-9 and NANA
and the effects of these ligand on the signaling processes of the inflammatory demyelination. Materials and
methods: Human Glial cell line was prepared from “Pasteur Institute of Iran” and cultured in DMEM,
supplemented with 10% FBS. The IC50 value of NANA was obtained by MTT assay. Glial cell line was treated with
NANA (300,500 and 1000 µg/ml) for 24h to investigate the effects of these ligand on the expression of MMP-9.
Then total cellular RNA was isolated from approximately 6-5×106 Glial cells. 1000 ng of total RNA from each
sample was used into cDNA. Real-time PCR determined the expression level of the MMP-9 transcripts and REST
and SPSS software were used for analyze. Results: The results of MTT assay were analyzed by Excel software and
IC50 was obtained equivalent to 1273.3 µM. Therefore, the concentration of Sialic acid was selected for
treatments that were less than Ic50 (300,500 and 1000 µM). By analyzing Real-time data, it was found that MMP-9
mRNA expression was up-regulated with treatment and indicated a possible involvement NANA on signaling
pathway this gene expression. Conclusion: By determining the possible relationship between NANA and MMP-9
gene expression, which is one of a key inflammation factors in some neurodegenerative diseases, should be
investigated MMPs gene control agents (including TIMPs and miRNAs); as well as other inflammatory
macromolecules such as cytokines, chemokines, prostaglandins, NO and ROS.
© 2016 Published by CASRP publishing company Ltd. UK. Selection and/or peer-review under responsibility of
Center of Advanced Scientific Research and Publications Ltd. UK.
Keywords: Sialic acid (N-acetylneuraminic acid), NANA, MMP-9, Glial cell line, Multiple Sclerosis (MS).
How to cite this article: Shabani Sadr, N.K., Shafiei, M., Galedari, H., Khirolah, A., 2016. Study of MMP-9 gene
expression in the presence of Sialic acid in human Glial cell line. 1st International Conference on Medicine, Public
Health and Biological Sciences (MPHBS), Sep. 2016.
Access this article online
Website: www.casrp.co.uk/conferences
DOI: 10.18869/MPHBS.2016.118
Available online at http://www.casrp.co.uk/conferences
CASRP Publisher

More Related Content

Viewers also liked

Molecular mechanisms final
Molecular mechanisms finalMolecular mechanisms final
Molecular mechanisms finalmosaiques
 
Mission Mode Project (MMP)
Mission Mode Project (MMP)Mission Mode Project (MMP)
Mission Mode Project (MMP)Meenu S
 
matrix metallo proteases (MMPs)
matrix metallo proteases (MMPs)matrix metallo proteases (MMPs)
matrix metallo proteases (MMPs)Vijay Avin BR
 
project report on matrix cellular services
project report on matrix cellular servicesproject report on matrix cellular services
project report on matrix cellular servicesamit1612
 

Viewers also liked (6)

KeyStone2011_b2-DY
KeyStone2011_b2-DYKeyStone2011_b2-DY
KeyStone2011_b2-DY
 
Molecular mechanisms final
Molecular mechanisms finalMolecular mechanisms final
Molecular mechanisms final
 
Mission Mode Project (MMP)
Mission Mode Project (MMP)Mission Mode Project (MMP)
Mission Mode Project (MMP)
 
Ecm
EcmEcm
Ecm
 
matrix metallo proteases (MMPs)
matrix metallo proteases (MMPs)matrix metallo proteases (MMPs)
matrix metallo proteases (MMPs)
 
project report on matrix cellular services
project report on matrix cellular servicesproject report on matrix cellular services
project report on matrix cellular services
 

Similar to MPHBS-2016-488-118

Bmc Cancer Mmp3 2010
Bmc Cancer  Mmp3 2010Bmc Cancer  Mmp3 2010
Bmc Cancer Mmp3 2010rm8509
 
Nucl. Acids Res.-2014-Di Lorenzo-8297-309
Nucl. Acids Res.-2014-Di Lorenzo-8297-309Nucl. Acids Res.-2014-Di Lorenzo-8297-309
Nucl. Acids Res.-2014-Di Lorenzo-8297-309Alessandra Di Lorenzo
 
Misner Kauss Singh et al NAMPT cardiotox CardioVascular Tox 2016
Misner Kauss Singh et al NAMPT cardiotox CardioVascular Tox 2016Misner Kauss Singh et al NAMPT cardiotox CardioVascular Tox 2016
Misner Kauss Singh et al NAMPT cardiotox CardioVascular Tox 2016Jatinder Singh, PhD, ERT.
 
Antisense technologies and antisense oligonucleotides
Antisense technologies and antisense oligonucleotidesAntisense technologies and antisense oligonucleotides
Antisense technologies and antisense oligonucleotidesRangnathChikane
 
The Study of Routine Laboratory Factors in Children with Mycoplasma Pneumonia...
The Study of Routine Laboratory Factors in Children with Mycoplasma Pneumonia...The Study of Routine Laboratory Factors in Children with Mycoplasma Pneumonia...
The Study of Routine Laboratory Factors in Children with Mycoplasma Pneumonia...HygeniaMirabel
 
The Study of Routine Laboratory Factors in Children with Mycoplasma Pneumonia...
The Study of Routine Laboratory Factors in Children with Mycoplasma Pneumonia...The Study of Routine Laboratory Factors in Children with Mycoplasma Pneumonia...
The Study of Routine Laboratory Factors in Children with Mycoplasma Pneumonia...Hygenia Hyacinth Mirabel
 
Antisense technologies and antisense oligonucleotides
Antisense technologies and antisense oligonucleotidesAntisense technologies and antisense oligonucleotides
Antisense technologies and antisense oligonucleotidesRangnathChikane
 
Pancreatology - Molecular Biology - Isabella Pel%C3%A1ez C.pdf
Pancreatology - Molecular Biology - Isabella Pel%C3%A1ez C.pdfPancreatology - Molecular Biology - Isabella Pel%C3%A1ez C.pdf
Pancreatology - Molecular Biology - Isabella Pel%C3%A1ez C.pdfIsabellaPelaez3
 
Nanolipoparticles-mediated MDR1 siRNA delivery: preparation, characterization...
Nanolipoparticles-mediated MDR1 siRNA delivery: preparation, characterization...Nanolipoparticles-mediated MDR1 siRNA delivery: preparation, characterization...
Nanolipoparticles-mediated MDR1 siRNA delivery: preparation, characterization...Nanomedicine Journal (NMJ)
 
TRANSPARENT AI/ML TO DISCOVER NOVEL THERAPEUTICS FOR RNA SPLICING-MEDIATED DI...
TRANSPARENT AI/ML TO DISCOVER NOVEL THERAPEUTICS FOR RNA SPLICING-MEDIATED DI...TRANSPARENT AI/ML TO DISCOVER NOVEL THERAPEUTICS FOR RNA SPLICING-MEDIATED DI...
TRANSPARENT AI/ML TO DISCOVER NOVEL THERAPEUTICS FOR RNA SPLICING-MEDIATED DI...iQHub
 

Similar to MPHBS-2016-488-118 (20)

Bmc Cancer Mmp3 2010
Bmc Cancer  Mmp3 2010Bmc Cancer  Mmp3 2010
Bmc Cancer Mmp3 2010
 
4640-63316-1-PB
4640-63316-1-PB4640-63316-1-PB
4640-63316-1-PB
 
Nucl. Acids Res.-2014-Di Lorenzo-8297-309
Nucl. Acids Res.-2014-Di Lorenzo-8297-309Nucl. Acids Res.-2014-Di Lorenzo-8297-309
Nucl. Acids Res.-2014-Di Lorenzo-8297-309
 
Misner Kauss Singh et al NAMPT cardiotox CardioVascular Tox 2016
Misner Kauss Singh et al NAMPT cardiotox CardioVascular Tox 2016Misner Kauss Singh et al NAMPT cardiotox CardioVascular Tox 2016
Misner Kauss Singh et al NAMPT cardiotox CardioVascular Tox 2016
 
Oncotarget-2016
Oncotarget-2016Oncotarget-2016
Oncotarget-2016
 
Antisense technologies and antisense oligonucleotides
Antisense technologies and antisense oligonucleotidesAntisense technologies and antisense oligonucleotides
Antisense technologies and antisense oligonucleotides
 
Dassie et al. Mol Ther 2014
Dassie et al. Mol Ther 2014Dassie et al. Mol Ther 2014
Dassie et al. Mol Ther 2014
 
The Study of Routine Laboratory Factors in Children with Mycoplasma Pneumonia...
The Study of Routine Laboratory Factors in Children with Mycoplasma Pneumonia...The Study of Routine Laboratory Factors in Children with Mycoplasma Pneumonia...
The Study of Routine Laboratory Factors in Children with Mycoplasma Pneumonia...
 
The Study of Routine Laboratory Factors in Children with Mycoplasma Pneumonia...
The Study of Routine Laboratory Factors in Children with Mycoplasma Pneumonia...The Study of Routine Laboratory Factors in Children with Mycoplasma Pneumonia...
The Study of Routine Laboratory Factors in Children with Mycoplasma Pneumonia...
 
Antisense technologies and antisense oligonucleotides
Antisense technologies and antisense oligonucleotidesAntisense technologies and antisense oligonucleotides
Antisense technologies and antisense oligonucleotides
 
Olaparib Upregulates miR-630 Expression to Enhance the Chemotherapeutic Sensi...
Olaparib Upregulates miR-630 Expression to Enhance the Chemotherapeutic Sensi...Olaparib Upregulates miR-630 Expression to Enhance the Chemotherapeutic Sensi...
Olaparib Upregulates miR-630 Expression to Enhance the Chemotherapeutic Sensi...
 
Okoye_NMDAR Inhibition Poster
Okoye_NMDAR Inhibition PosterOkoye_NMDAR Inhibition Poster
Okoye_NMDAR Inhibition Poster
 
Pancreatology - Molecular Biology - Isabella Pel%C3%A1ez C.pdf
Pancreatology - Molecular Biology - Isabella Pel%C3%A1ez C.pdfPancreatology - Molecular Biology - Isabella Pel%C3%A1ez C.pdf
Pancreatology - Molecular Biology - Isabella Pel%C3%A1ez C.pdf
 
Annals of Mutagenesis
Annals of Mutagenesis Annals of Mutagenesis
Annals of Mutagenesis
 
Antisense therapy
Antisense therapyAntisense therapy
Antisense therapy
 
seminario biomol.pptx
seminario biomol.pptxseminario biomol.pptx
seminario biomol.pptx
 
Nanolipoparticles-mediated MDR1 siRNA delivery: preparation, characterization...
Nanolipoparticles-mediated MDR1 siRNA delivery: preparation, characterization...Nanolipoparticles-mediated MDR1 siRNA delivery: preparation, characterization...
Nanolipoparticles-mediated MDR1 siRNA delivery: preparation, characterization...
 
4 nmj 2-1
4   nmj 2-14   nmj 2-1
4 nmj 2-1
 
TRANSPARENT AI/ML TO DISCOVER NOVEL THERAPEUTICS FOR RNA SPLICING-MEDIATED DI...
TRANSPARENT AI/ML TO DISCOVER NOVEL THERAPEUTICS FOR RNA SPLICING-MEDIATED DI...TRANSPARENT AI/ML TO DISCOVER NOVEL THERAPEUTICS FOR RNA SPLICING-MEDIATED DI...
TRANSPARENT AI/ML TO DISCOVER NOVEL THERAPEUTICS FOR RNA SPLICING-MEDIATED DI...
 
Austin Rheumatology
Austin RheumatologyAustin Rheumatology
Austin Rheumatology
 

More from shahid chamran university of Ahvaz (6)

MTT
MTTMTT
MTT
 
poster
posterposter
poster
 
RNA interference in Biology and medicine
RNA interference in Biology and medicine RNA interference in Biology and medicine
RNA interference in Biology and medicine
 
Schizophrenia and Genetic
Schizophrenia and GeneticSchizophrenia and Genetic
Schizophrenia and Genetic
 
Cancer and CNV
Cancer and CNVCancer and CNV
Cancer and CNV
 
Pharmacogenomics
PharmacogenomicsPharmacogenomics
Pharmacogenomics
 

MPHBS-2016-488-118

  • 1. *Corresponding Author: Hamid Galedari 118 1st International Conference on Medicine, Public Health and Biological Sciences (MPHBS) Study of MMP-9 gene expression in the presence of Sialic acid in human Glial cell line Narjes Khatoun Shabani Sadr1 , Mouhammad Shafiei1 , Hamid Galedari1,* , Alireza Khirolah2 1 Department of Genetic, Faculty of Sciences, Shahid Chamran University of Ahvaz, Ahvaz, Iran. 2 Department of Biochemistry, Medical School, Cellular and Molecular Research Center, Ahvaz Jundishapur University of Medical Science, Ahvaz, Iran. Abstract Introduction: Sialic acid (N-acetylneuraminic acid, NANA) is found at all cell surfaces of vertebrates which can cause many different reactions, such as starting or inhibiting the immune response, the activating of the complement system and cell signaling. Sialic acid involvement in the signaling pathways leading to MMP-9 expression in Glial cells is unclear. Therefore, this study investigated the relationship between MMP-9 and NANA and the effects of these ligand on the signaling processes of the inflammatory demyelination. Materials and methods: Human Glial cell line was prepared from “Pasteur Institute of Iran” and cultured in DMEM, supplemented with 10% FBS. The IC50 value of NANA was obtained by MTT assay. Glial cell line was treated with NANA (300,500 and 1000 µg/ml) for 24h to investigate the effects of these ligand on the expression of MMP-9. Then total cellular RNA was isolated from approximately 6-5×106 Glial cells. 1000 ng of total RNA from each sample was used into cDNA. Real-time PCR determined the expression level of the MMP-9 transcripts and REST and SPSS software were used for analyze. Results: The results of MTT assay were analyzed by Excel software and IC50 was obtained equivalent to 1273.3 µM. Therefore, the concentration of Sialic acid was selected for treatments that were less than Ic50 (300,500 and 1000 µM). By analyzing Real-time data, it was found that MMP-9 mRNA expression was up-regulated with treatment and indicated a possible involvement NANA on signaling pathway this gene expression. Conclusion: By determining the possible relationship between NANA and MMP-9 gene expression, which is one of a key inflammation factors in some neurodegenerative diseases, should be investigated MMPs gene control agents (including TIMPs and miRNAs); as well as other inflammatory macromolecules such as cytokines, chemokines, prostaglandins, NO and ROS. © 2016 Published by CASRP publishing company Ltd. UK. Selection and/or peer-review under responsibility of Center of Advanced Scientific Research and Publications Ltd. UK. Keywords: Sialic acid (N-acetylneuraminic acid), NANA, MMP-9, Glial cell line, Multiple Sclerosis (MS). How to cite this article: Shabani Sadr, N.K., Shafiei, M., Galedari, H., Khirolah, A., 2016. Study of MMP-9 gene expression in the presence of Sialic acid in human Glial cell line. 1st International Conference on Medicine, Public Health and Biological Sciences (MPHBS), Sep. 2016. Access this article online Website: www.casrp.co.uk/conferences DOI: 10.18869/MPHBS.2016.118 Available online at http://www.casrp.co.uk/conferences CASRP Publisher